Skip to content

Construction, Implementation, and Application of an Auxiliary Diagnostic and Therapeutic System for Degenerative Lumbar Spinal Stenosis Based on Clinical Practice Guidelines.

Construction, Implementation, and Application of an Auxiliary Diagnostic and Therapeutic System for Degenerative Lumbar Spinal Stenosis Based on Clinical Practice Guidelines.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001321
Enrollment
Unknown
Registered
2026-05-26
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative lumbar spinal stenosis

Interventions

Experimental Group:PtDA is utilized to generate a treatment plan that best matches the patient's current condition, with basic treatment methods including acupuncture, massage therapy, and oral medica
Control Group:The control group does not use PtDA and completes treatment by distributing paper-based intervention materials to both doctors and patients. Their intervention measures are the same as t

Sponsors

Beijing University of Chinese Medicine Dongzhimen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Applicability Assessment (Phase 4) (1) Inclusion criteria for doctors and nurses: Select 8 doctors and 8 nurses who are willing to participate in the study, have different sociodemographic characteristics (age, gender, academic/medical background, different levels of healthcare institutions, different professional backgrounds), and are employed at Beijing University of Chinese Medicine Dongzhimen Hospital, Changping District Longze Garden Community Health Service Center, Tongzhou District Yongshun Community Health Service Center, or Beijing Heshoutang Chinese Medicine Hospital. (2) Inclusion criteria for patients: Each healthcare provider selects 1 DLSS patient who meets the following requirements: different sociodemographic characteristics (gender, education level, different imaging features), aged 18-65, signs an informed consent form, and is willing to participate in an interview. 2. Feasibility Trial and Post-Trial Interviews (Phase 5, Phase 6): (1) Inclusion criteria for doctors: Recruit clinical doctors who have been working for more than 5 years, see more than 30 DLSS patients annually, and are willing to participate in the study at the hospital where the principal investigator is located. (2) Inclusion criteria for patients: Researchers will use electronic medical records in the practices of consenting doctors to identify DLSS patients who meet the above diagnostic criteria, are aged 18-65, sign an informed consent form, and are willing to participate in follow-ups. (3) Inclusion criteria for patient caregivers: Researchers will select 1 caregiver who is a direct relative or primary caregiver of the patient, with the patient's consent. The caregiver must have participated to some extent in the research process, be at least 18 years old, sign an informed consent form, and be willing to participate in follow-ups.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for doctors and nurses: Those who are unable to cooperate to complete the study and evaluation due to clinical work or other reasons. 2. Exclusion criteria for patients: This includes patients with mental disorders or communication barriers, those unable to provide informed consent, pregnant or breastfeeding women, those with limited life expectancy (<1 year), those unable to be followed up, or those participating in other studies. 3. Exclusion criteria for patients' family members: Those with hearing or comprehension impairments, unable to communicate effectively, unable to provide informed consent, those with severe mental or physical illnesses where participation in this interview would cause discomfort or risk, or those with other circumstances that may affect the quality of the interview or research ethics.

Design outcomes

Primary

MeasureTime frame
Decisional Conflict Scale;

Secondary

MeasureTime frame
Zurich Claudication questionnaire;Short Form-12 Health Survey;Chronic Illness Care;Assessment of Willingness to Participate in Shared Decision Making;Qualitative interview data;Adverse Event;

Countries

China

Contacts

Public ContactWang Xiyou

Beijing University of Chinese Medicine Dongzhimen Hospital

dwxy658@163.com13810111889

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026